Quarry LP Buys 166 Shares of Chemed Co. (NYSE:CHE)

Quarry LP boosted its stake in Chemed Co. (NYSE:CHE) by 721.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 189 shares of the company’s stock after acquiring an additional 166 shares during the period. Quarry LP’s holdings in Chemed were worth $103,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Second Line Capital LLC increased its position in shares of Chemed by 7.6% during the second quarter. Second Line Capital LLC now owns 3,925 shares of the company’s stock worth $2,130,000 after buying an additional 277 shares during the period. Creative Planning raised its position in shares of Chemed by 2.8% in the 2nd quarter. Creative Planning now owns 1,228 shares of the company’s stock worth $667,000 after acquiring an additional 34 shares in the last quarter. Algert Global LLC lifted its stake in shares of Chemed by 10.8% in the 2nd quarter. Algert Global LLC now owns 11,540 shares of the company’s stock valued at $6,261,000 after purchasing an additional 1,129 shares during the period. Mackenzie Financial Corp boosted its position in shares of Chemed by 107.2% during the 2nd quarter. Mackenzie Financial Corp now owns 5,732 shares of the company’s stock valued at $3,110,000 after purchasing an additional 2,966 shares in the last quarter. Finally, Millennium Management LLC grew its stake in Chemed by 126.5% during the second quarter. Millennium Management LLC now owns 39,344 shares of the company’s stock worth $21,347,000 after purchasing an additional 21,974 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Chemed Stock Performance

Shares of CHE opened at $592.70 on Wednesday. The firm has a market cap of $8.97 billion, a PE ratio of 31.90, a price-to-earnings-growth ratio of 2.40 and a beta of 0.44. Chemed Co. has a 52-week low of $497.36 and a 52-week high of $654.62. The business’s 50 day moving average price is $575.72 and its two-hundred day moving average price is $575.12.

Chemed (NYSE:CHE) last issued its earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The company had revenue of $595.88 million for the quarter, compared to the consensus estimate of $599.20 million. During the same period in the prior year, the company earned $4.71 earnings per share. The firm’s revenue was up 7.6% compared to the same quarter last year. Research analysts predict that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend was Monday, August 12th. This is a boost from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio (DPR) is 10.76%.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Monday, August 5th. The shares were sold at an average price of $569.63, for a total value of $1,139,260.00. Following the completion of the sale, the chief executive officer now owns 105,735 shares of the company’s stock, valued at approximately $60,229,828.05. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, Director George J. Walsh III sold 200 shares of Chemed stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total transaction of $115,590.00. Following the transaction, the director now owns 3,446 shares of the company’s stock, valued at $1,991,615.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $569.63, for a total value of $1,139,260.00. Following the transaction, the chief executive officer now directly owns 105,735 shares in the company, valued at approximately $60,229,828.05. The disclosure for this sale can be found here. Insiders sold a total of 9,144 shares of company stock worth $5,264,839 over the last quarter. 3.32% of the stock is currently owned by corporate insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.